FGFR2 and cholangiocarcinoma: The authors found a significantly lower number of somatic mutations in CCA than in GBC and described new driver fibroblast growth factor receptor 2 (FGFR2) fusion genes, exclusively detected in iCCA, to complete the list of already-described gene fusions [101,102].